ReviewCureus2024

Evaluating Cardiovascular Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in Type 2 Diabetes Mellitus: A Systematic Review.

Chithra Sreenivasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.